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Biochemistry
Purification of a factor that restores translation of vesicular
stomatitis virus mRNA in extracts from poliovirus-infected
HeLa cells
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ABSTRACT It was previously shown that the poliovirus-
induced inhibition of translation of capped mRNAs can be re-
versed by a protein found in preparations of the eukaryotic
initiation factor eIF-4B [Rose, J. K, Trachsel, H., Leong, K. &
Baltimore, D. (1978) Proc. Nat]. Acad. Sci. USA 75, 2732-27"J.
This "restoring factor" has now been purified from a high-salt
wash of rabbit reticulocyte ribosomes by taking advantage of
its tight association with factor eIF-3 at low salt concentrations.
It did not.copurify with the major Mr 80,000 polypeptide of
eIF-4B preparations but did copurify with a Mr 24,000 poly-
peptide previously shown to bind to the cap structures of mRNAs[Sonenberg, N., Rupprecht, K. M., Hecht, S. M. & Shatkin, A. J.(1979) Proc. Nati. Acad. Sci. USA 76, 4345-43491. Both the
electrophoretic mobility and the tryptic peptide pattern of the
restoring factor were indistinguishable from those of the cap-
binding protein, and the restoring factor could be crosslinked
to the 5'-terminal cap on mRNA. Thus, it appears that poliovirus
inhibits cellular protein synthesis by inactivation of some crucial
property of the cap-binding protein.
Picornavirus infection inhibits translation of host cell mRNA
(1). This inhibition has been shown to occur at the level of
translation initiation (2) and not at the level of mRNA degra-
dation (3) or mRNA modification (4). Furthermore, it was
shown in cell-free protein-synthesizing systems that the ribo-
somal salt wash from poliovirus-infected cells does not stimulate
the translation of host mRNAs from uninfected cells (5) but
stimulates the translation of poliovirus RNA (6).
Vesicular stomatitis virus (VSV) mRNAs can be used as an-
alogs of host mRNA because their translation is inhibited by
superinfection of VSV-infected cells with poliovirus (7, 8). By
using nuclease-treated cell-free extracts it has been shown that
preparations of the eukaryotic initiation factor 4B (eIF-4B)tt
can restore VSV mRNA translation in extracts from poliovi-
rus-infected HeLa cells (10). It was therefore suggested that loss
of eIF-4B activity could be responsible for the inhibition of VSV
mRNA translation. One feature whereby the factor could dis-
criminate between poliovirus RNA and VSV mRNAs (or host
mRNAs) lies in the 5'-terminal cap structure (m7GpppN)
present on all known animal cell and viral mRNAs except those
of picornaviruses (11). Although there has been some indication
that eIF-4B interacts with the cap (12), more recent evidence
has shown that eIF-4B (and eIF-3) preparations contain a Mr
24,000 protein that specifically binds to the 5'-terminal cap
structure of eukaryotic mRNAs (13). This finding raises the
possibility that some of the properties of eIF-4B preparations
(10, 14) can be accounted for by the presence of the Mr 24,000
polypeptide in eIF-4B preparations. We therefore undertook
purification of the activity that restores the activity of extracts
from poliovirus-infected HeLa cells (hereafter referred to as
"restoring factor") in order to clarify its nature and its rela-
tionship to the Mr 24,000 polypeptide. Here, we present evi-
dence that it is identical to the cap-binding protein (13, 15).
MATERIALS AND METHODS
Buffers. Buffer A: 20 mM Tris-HCI, pH 7.6/0.1 mM
EDTA/5 mM 2-mercaptoethanol. Buffer B: 20 mM Tris-HCI,
pH 7.6/0.1 mM EDTA/5 mM 2-mercaptoethanol/10% (vol/
vol) glycerol.
Cell-Free Translation in Extracts from Poliovirus-Infected
HeLa Cells. The growth of HeLa cells, poliovirus infection, and
the preparation of the micrococcal nuclease-treated translation
system were as described (10). The cell-free translation system
was made with an extract from poliovirus-infected HeLa cells
(3 hr after infection). The reaction mixtures (12.5 Mil) were as
described (10) with 0.5 ,Ag of VSV mRNA and a supplement of
0.5 ,ug of eIF-2. After incubation (60 min at 350C), 5-,ul aliquots
were spotted on filter papers, soaked in cold 5% trichloroacetic
acid, and then heated for 5 min at 900C. The filters were rinsed
in 5% trichloroacetic acid, absolute ethanol, and acetone and
dried under a heat lamp. Incorporation of [3aSimethionine (1150
Ci/mmol, Amersham; 1 Ci = 3.7 X 1010 becquerels) was
measured in 2,5-diphenyloxazole/1,4-bis[2-(5-phenyloxazo-
lyl)]benzene/toluene in a liquid scintillation counter.
One unit of restoring factor was defined as the amount of
factor that restored [35S]methionine incorporation in the stan-
dard reaction mixture to 50% of the value obtained in the
presence of 0.5 ,ul of step 5 preparation (the same preparation
was used as the standard throughout the purification). The
linearity of the assay is shown in Fig. 1.
NaDodSO4/Polyacrylamide Gel Electrophoresis. Elec-
trophoresis in slab gels was according to Laemmli (16). The
separating gel contained 15% acrylamide (wt/vol) and 0.086%
bisacrylamide (wt/vol).
Assay for Initiation Factor (eIF-3, eIF4B) Activity. Frac-
tions obtained by sucrose density gradient sedimentation were
tested for initiation factor activity in the globin mRNA-de-
Abbreviations: VSV, vesicular stomatitis virus; eIF, eukaryotic initiation
factor.
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FIG. 1. Effect of restoring factor on VSV mRNA translation. Step
5 restoring factor preparation (9 /ig/,gl) was titrated in the standard
poliovirus-infected HeLa incubation mixture for cell-free translation.
Background incorporation in the absence of added factor (1300 cpm)
was subtracted.
pendent polypeptide synthesis system b with the omission of
either eIF-3 or eIF-4B (according to which factor was being
assayed) as described by Schreier et al. (17).
Tryptic Peptide Analysis. Protein bands from fixed and
stained NaDodSO4/polyacrylamide gels were cut out and the
protein was labeled with 12'I (1 mCi/band) and digested with
trypsin, and the tryptic digests were analyzed. The procedure
of Elder et al. (18) was followed.
Crosslinking of Protein to mRNA. Restoring factor was
incubated with periodate-oxidized [3H]methyl-labeled reovirus
mRNA, and complexes were stabilized by reduction with
NaBH3CN, treated with RNase, and analyzed as described (13,
19).
Purification of the Restoring Factor. All operations were
done at 0-40C. Rabbit reticulocyte polysomes were prepared
as described by Schreier et al. (17); 53,000 A2660 units of poly-
somes were diluted to 400 ml. The final ionic conditions were
20 mM Tris-HCI, pH 7.6/500 mM KCI/6 mM Mg(OAc)2/5
mM 2-mercaptoethanol/250 mM sucrose. The polysomes were
pelleted by centrifugation in a Beckman type 35 rotor at 30,000
rpm for 8.5 hr at 20C.
Step 1. Ammonium sulfate fractionation. The supernatant
fraction (ribosomal wash) was precipitated by the addition of
crystalline (NH4)2SO4 to 40% saturation, and the precipitate
was collected by centrifugation, dissolved in buffer A containing
100 mM KCI, and dialyzed against this buffer overnight. The
protein concentration was determined according to Warburg
and Christian (20).
Step 2. Sucrose gradient centrifugation. Eighteen milliliters
of step 1 preparation (414 mg of protein) was loaded on six
10-40% exponential sucrose gradients in buffer A containing
100 mM KCI and centrifuged in a Beckman SW 27 rotor at
25,000 rpm for 42 hr at 20C. The gradients were fractionated
(1.5 ml per fraction) and corresponding fractions from the six
gradients were pooled. The restoring factor activity sedimented
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FIG. 2. Sucrose gradient centrifugation. The samples, centrifu-
gation conditions (A, low salt; B, high salt), and assays for factor ac-
tivities are described in Materials and Methods (steps 2 and 3).
Sedimentation is from right to left. Aliquots of fractions (volumes
indicated in parentheses) were tested for factor activity: 0, restoring
factor (A, 4 Al; B, 3 Al); A, eIF-3 (A, 3 Al; B, 2Ml); or *, eIF-4B (A, 5
Ml).
with eIF-3 (Fig. 2A). Fractions 1-7 were pooled, precipitated
by the addition of (NH4)2SO4 to 50% saturation, resuspended
in 5 ml of buffer A containing 100 mM KC1, and dialyzed
against this buffer overnight.
Step 3. Sucrose gradient centrifugation. Five milliliters of
step 2 preparation (70 mg of protein) was adjusted to 0.5 M KC1,
loaded on four 10-45% exponential sucrose gradients in buffer
A containing 0.5 M KC1, and centrifuged in the Beckman SW
41 rotor at 39,000 rpm for 21 hr at 20C. Fractions (0.5 ml) were
collected and assayed for eIF-3 and restoring factor activity.
Under these high-salt conditions, the two activities were sepa-
rated (Fig. 2B). Fractions 16-22 were pooled, precipitated as
described above, dissolved in 2.2 ml of buffer B containing 50
mM KCI, and dialyzed against this buffer overnight.
Step 4. DEAE-cellulose chromatography. Of the step 3
preparation, 0.8 ml (3.6 mg of protein, 1000 units) was applied
to a DEAE-cellulose column (Whatman DE-52, 1.2 X 4 cm)
equilibrated with buffer B containing 50 mM KCL. The column
was washed with this buffer and then step-eluted with buffer
B containing 150 mM KCI for the first step and 300 mM KCI
for the second step. About 85% of the recovered restoring factor
activity eluted at 150 mM KCL.
Step 5. Phosphocellulose chromatography. Two milliliters
of step 4 preparation (2.5 mg of protein) was diluted to 3 ml
1:
i
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with buffer B to adjust the KCl concentration to 100 mM. This
preparation was applied to a phosphocellulose column
(Whatman P11, 0.8 X 4.5 cm) equilibrated with buffer B con-
taining 100mM KCl. The column was washed with this buffer
and then step-eluted with buffer B containing 200mM KCl for
the first step and 400mM KCl for the second step. About 95%
of the recovered restoring factor activity eluted at 400mM KCl.
The active fraction (1 ml) was dialyzed against buffer B con-
taining 50 mM KC1 for 2 hr at 4VC.
Step 6. Affinity chromatography. The initiation factor eIF-3
(7.5 A2g units of protein) was coupled to CNBr-activated
Sepharose 4B (1.5 g) as described by the maker (21). One mil-
liliter of step 5 preparation (0.9 mg of protein) was applied to
an eIF-3-Sepharose affinity column (0.8 X 4 cm) equilibrated
with buffer B containing 100mM KCI. The column was washed
with this buffer and then step-eluted with buffer B containing
500 mM KC1. More-than 90% of the restoring factor activity
eluted at 500mM KCl (Fig. 3). The active fractions (2 ml, 0.09
mg of protein) were dialyzed against buffer B containing 100
mM KClfor 2 hr at4C.
Step 7. Phosphocellulose chromatography. Step 6 prepa-
ration was applied to a phosphocellulose column (0.5 X 2.5 cm)
equilibrated with buffer B containing 100 mM KC1. The col-
umn was washed and protein was eluted as described for step
5. The restoring factor activity was found in the 400 mM KC1
fraction (Table 1).
RESULTS
It was previously shown that a protein in eIF-4B preparations
is able to restore VSV mRNA translation in extracts of poliovi-
rus-infected HeLa cells (10). The major polypeptide in eIF-4B
preparations has a molecular weight of 80,000 (17, 22). To ex-
amine whether the Mr 80,000 polypeptide in eIF-4B prepa-
rations was responsible for the restoring activity, the restoring
activity was directly purified from the salt wash of reticulocyte
ribosomes.
When the 0-40% saturated (NH4)2SO4 precipitate derived
from a salt wash preparation was sedimented through a sucrose
gradient at low ionic strength, the restoring activity sedimented
with initiation factor eIF-3 (Fig. 2A). At a high salt concen-
tration, however, the restoring activity could be separated from
eIF-S (Fig. 2B), suggesting that the factor binds to eIF-3 (see
below). This result is also consistent with the previous finding
that high-salt-purified eIF-3 did not have restoring activity (10).
In low ionic strength sucrose gradients, an activity that stimu-
lated an eIF-4B-deficient cell-free protein-synthesizing system
was separable both from eIF-3 and from the restoring activity
(Fig. 2A).
The restoring activity was further purified by DEAE-cel-
lulose and phosphocellulose chromatography. The active ma-
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FIG. 3. eIF-3-Sepharose affinity chromatography of restoring
factor activity (step 6). One-milliliter fractions were collected and 3-,ul
aliquots were tested for restoring factor activity.
Table 1. Phosphocellulose chromatography (step 7)
Addition to assay
None
Control factor (0.5 ,u1)
Void fractions (pooled)
200 mM KCl
Fraction 2
3
4
400mM KCl
Fraction 1
2
3
4
[35S]Methionine
incorp., cpm
3,024
26,523
2,561
2,657
2,509
2,899
2,747
7,140
13,379
8,935
Phosphocellulose chromatography: 100-,ul fractions were collected(void fractions were pooled) and 3-il aliquots were assayed for re-
storing factor activity. Control factor was step 5 preparation (see Fig.
1).
terial was then passed through a column containing eIF-3 that
had been immobilized by linkage to Sepharose. Unlike the bulk
of the protein, the restoring activity bound quantitatively to the
eIF-3 affinity column (Fig. 3). As a final purification step, a
second phosphocellulose chromatography was used. A summary
of the purification process is shown in Table 2.
After purification through the first phosphocellulose chro-
matography step, the restoring activity remained very stable
even upon storage at room temperature overnight. After af-
finity chromatography, however, the activity became labile,
and this material or restoring factor that had been purified
through a second phosphocellulose column lost most of its ac-
tivity on storage overnight at -70°C or in liquid nitrogen.
Upon analysis of the various fractions during purification by
NaDodSO4/polyacrylamide gel electrophoresis, a selective
enrichment of an Mr 24,000 polypeptide was evident (Fig. 4,
slots b-g). The cap-binding protein (15), analyzed in slot h (Fig.
a b c d k
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FIG. 4. NaDodSO4/polyacrylamide gel electrophoresis. (A)
Stained lanes from different gels are shown. Slot a, marker proteins
(Mr X 10-3 given on the left): bovine serum albumin (68,000), oval-
bumin (43,000), chymotrypsin (25,000), lysozyme (14,000). Slot b, 28
Mg (1.3 units) of step 2 factor; slot c, 22 ,ug (6 units) of step 3 factor;
slot d, 15 ,ig (5 units) of step 4 factor; slot e, 9 ,ug (5 units) of step 5
factor; slot f, 4 Mg (12 units) of step 6 factor; slot g, 0.8 ,ug (12 units)
of step 7 factor; slot h, 2 ug of cap-binding protein purified as de-
scribed (15); slot i, sample buffer. The faint band in the region OfMr
68,000 (slots g and h) is an artefact also observed in a slot containing
only sample buffer (slot i). (B) Restoring factor purified through steps
1-5 and 7 was crosslinked to the cap structure of mRNA. Slot k, 7.5
,Mg of factor, not crosslinked (stained gel); slot 1, 2.5 Mug of factor,
crosslinked (autoradiography). The arrows point to the Mr 24,000
polypeptide.
0.5 M K+
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Table 2. Summary of purification
Total protein, Specific activity, Purification, Recovery,
Step mg units per mg fold %
1. (NH4)2SO4 cut 414 9.5 1 100
2. Sucrose gradient (low salt) 70 46 4.9 82
3. Sucrose gradient (high salt) 10 282 29.8 72
4. DEAE-cellulose chromatography 2.5 344 36.2 62*
5. Phosphocellulose chromatography 0.9 555 58.7 36*
6. Affinity chromatography 0.09 3,233 342 21*
7. Second phosphocellulose chromatography 0.004t 14,500 1526 4*
* Of the step 3 preparation, 3.6 mg was further purified; recovery was corrected for this.
t Estimated from stained NaDodSO4 gel.
4), comigrated during electrophoresis with the major poly-
peptide in the restoring activity. Furthermore, the Mr 24,000
polypeptide in the restoring activity could be selectively
crosslinked to the 5'-terminal cap structure of messenger RNA
by using the procedure described (19) (Fig. 4, slots k and 1).
These results suggest that the cap-binding protein and the Mr
24,000 restoring activity are identical polypeptides.
To compare these two polypeptides structurally, their tryptic
digest patterns were examined. Although comparison of the two
patterns (Fig. 5 A and B) showed differences in relative in-
tensity of spots, a mixture of the two preparations showed that
the spots overlapped (Fig. 5C) and thus the two proteins appear
to be identical.
DISCUSSION
Using the restoration of VSV mRNA translation in extracts of
poliovirus-infected cells as an assay system, we were able to
identify an activity that selectively restored translation. The
activity copurified with an Mr 24,000 polypeptide that was
identical to the cap-binding protein (13,15) by electrophoretic
mobility in NaDodSO4/polyacrylamide gels, crosslinking to
the 5' terminus of mRNA, and tryptic peptide pattern. We
therefore assume that the restoring factor and the cap-binding
protein are identical. It is not certain, however, that inactivation
of the cap-binding protein completely explains the ability of
poliovirus infection to inhibit translation of host cell mRNAs.
A B
Other factors may interact with cap-binding protein, and until
these interactions are understood the action of poliovirus will
not be clear. It does appear from these data that one conse-
quence of poliovirus infection is modification of cap-binding
protein, but the nature of the modification and its consequence
remain to be shown.
Originally, eIF-4B was defined in a fractionated protein-
synthesizing system as a factor that stimulated initiation (17);
the factor was later shown to be involved in mRNA binding
(23). This activity copurified with a Mr 80,000 polypeptide (17,
22). Because all eIF-4B preparations tested recently also con-
tained low levels of the cap-binding protein, and because par-
tially purified preparations of cap-binding protein significantly
stimulated the fractionated system (results not shown), it may
be that this protein is partially responsible for the eIF-4B ac-
tivity described in the fractionated system (17, 22-24). Further
work will be needed to determine the relative contributions to
eIF-4B activity of these two polypeptides. The Mr 80,000
polypeptide separates from eIF-3 during sucrose gradient
centrifugation in low salt concentration (22) and may be re-
sponsible for the stimulation of the fractionated system by top
fractions of our sucrose gradients (Fig. 2A).
The restoring activity of purified cap-binding protein
preparations decreased rapidly during storage. Cruder prep-
arations, however, were stable and in addition were able to
reactivate purified cap-binding protein that had lost its restoring
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FIG. 5. Comparison of tryptic peptide patterns. The Mr 24,000 polypeptide (Fig. 4, slot f) and the cap-binding protein (Fig. 4, slot h) were
excised from the destained wet gel and further processed as described in Materials and Methods. The autoradiographs (exposure time 145 hr)
are shown. Electrophoresis was from right to left, chromatography from bottom to top. (A) Mr 24,000 restoring factor; (B) cap-binding protein
- (15); (C) equal amounts of A and B mixed.
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activity (results not shown). This suggests that an additional
component may be required to maintain the restoring activity
of purified cap-binding protein.
The finding that the restoring activity is identical with the
cap-binding protein fits into the scheme (10) whereby poliovirus
infection leads to the inactivation of the cap-dependent rec-
ognition mechanism of mRNAs during protein synthesis initi-
ation. This results in the inhibition of host mRNA but not pol-
iovirus RNA translation, because the latter lacks the 5' terminal
cap structure (25, 26) and presumably does not need cap-
binding protein for initiation. Consistent with this scheme,
purified cap-binding protein does not stimulate the translation
of poliovirus RNA in extracts from poliovirus-infected or un-
infected HeLa cells (results not shown). We find the cap-
binding protein associated with the complex initiation factor
eIF-3, however, in quite small amounts (Fig. 2): we calculate
from Table 2 (1 unit of activity z 70 ng of protein) and Fig. 2B
(45 A280 units of eIF-3 release 2820 units of restoring activity)
that the ratio of eIF-3 to cap-binding protein is at least 8:1. It
is possible that some cap-binding protein remains associated
with mRNA. The cap-binding protein might then serve as the
contact site for the recognition of the 5'-terminus of mRNA by
[40S ribosomal subunit-eIF-3J complexes, possibly as the first
step in mRNA binding.
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